Events & News
Pfizer Accepting Non-Confidential Preproposals for Certain Interest Areas
Posted June 1,2020:
Pfizer’s Centers for Therapeutic Innovation is seeking out pre-proposal applications in core research focus areas: oncology, inflammation &
immunology, internal medicine and rare diseases as outlined more specifically below. Non-confidential pre-proposals will be reviewed on a rolling basis from June 1st – September 28th.
- DNA Damage Response and Replicative Stress
- Repeat Expansion Diseases
- Cellular Senescence
- 组织免疫系统串扰
Download more information on these opportunities这里. Download Pfizer's pre-proposal template这里.
2020 Spring I-Corps Life Science Regional Program
Posted January 17, 2020:
德克萨斯大学医学博士Anderson癌症中心的创业发展中心很高兴为我们的2020年春季I-Corps Life Science区域计划开放应用程序门户。该计划向Uthealth团队开放，并向所有生命科学技术开放，包括诊断，数字健康，医疗设备，治疗学等。
Teams will be accepted on a rolling basis, with the first round of interviews beginning February 17th. The final application deadline is March 16th. However, applications may close earlier if all slots are full before March 16th.
博士。Mukherji，Cooley团队创建Airway Armor™
发表于2018年9月19日：博士。Mukherji and Cooley from the UTHealth School of Dentistry at Houston have developed the Airway Armor™, a guard that keeps small objects from falling down a patient's throat during dental procedures.
NCATS STTR Funding Opportunities Open for Academic Researchers & Entrepreneurs
Posted May 24, 2018: TheNational Center for Advancing Translational Sciences (NCATS)at the National Institutes of Health invites researchers at academic institutions to apply for小型企业技术转移（STTR）支持商业化创新。下一个申请截止日期是2018年9月5日，下午5:00当地时间。STTR计划是美国早期技术融资的最大来源之一
NCATS is interested in the development of innovative tools, technologies and intervention (drug, device, diagnostic) platforms that would support the creation of novel therapeutics. The NCATS SBIR & STTRresearch priorities包括：
STTR计划旨在资助涉及小型企业和研究机构的合作研发项目，即非营利学院或大学，联邦资助的研发中心或国beplay苹果手机能用吗内非营利研究组织。计划支持有助于弥合基础科学表现与产生创新的商业化之间的差距。申请人可以申请第一阶段或第二阶段资金。
Phase I:目的是建立拟议的研发工作的技术优点和可行性，并在在第二阶段提供进一步的联邦支持之前确定小型企业绩效的质量。beplay苹果手机能用吗Phase I support is typically $150,000 provided over a period of six months. However, with proper justification, applicants may propose longer periods of time and greater funding amounts necessary to establish the technical merit and feasibility of the proposed project, up $225,000 in total costs for one year.
Phase II:目的是继续在第一阶段发起的研发工作，在两年内通常为100万美元。beplay苹果手机能用吗有了理由和商业化计划，申请人可能会提议资金多达150万美元的总成本。
Benefits of Applying:
- Funding is stable, predictable and not a loan
- 资本是非二元的
- Small businesses retain intellectual property rights
- NIH的严格同行评审为早期公司提供了认可，验证和可见性
- 与这些奖项相关的声望可以帮助吸引更多的资金或其他支持（例如，风险资本，战略合作伙伴）
Upcoming Events:
- Wednesday, May 30 from 3:00 – 4:00 PM EST:免费网络研讨会SBIR / STTR资金,申请人中rt programs, and local resources by NCATS, NCI and the Women’s Business Development Center.Register now!
- June 4 – 7, BIO国际ional 2018 in Boston:NCAT将于今年在Bio！联系我们to set up a one-to-one meeting to discuss STTR funding opportunities and resources with Lili Portilla, Director of Strategic Alliances at NCATS.
Questions?Visit theNCATS small business opportunitieswebsite and emailNCATS-SBIRSTTR@mail.nih.govto discuss potential project ideas and related questions.
TMCX Open 2018医疗设备队列申请
截止日期：2018年5月14日
Application:https://gust.com/programs/tmcx-accelerator-medical-device-2018
TMCX降低了进入世界上最大的医疗中心的障碍，使初创公司能够利用我们从21个德克萨斯州医疗中心医院和我们量身定制的课程来利用我们广泛的顾问网络，以在临床上验证并找到适合其解决方案的产品市场。
TMCX医疗设备2017年的19家初创公司筹集了2600万美元，并在我们为期三个月的计划中以飞行员和协议的形式与潜在客户进行了超过43次交战。